Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 421-425

  Liu, Hao ^a   Zhang, Li ^a   Cybulsky, Myron ^a   Gorczynski, Reg ^a   Crookshank, Jennifer ^a   Manuel, Justin ^a   Grant, David ^a   Levy, Gary ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934443005     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_76     Document Type: Conference Paper

References (9)

1. Marsden, P. A., Ning, Q., Fung, L. S., Luo, X., Chen, Y., Mendicino, M., Ghanekar, A., Scott, J. A., Miller, T., Chan, C. W., Chan, M. W., He, W., Gorczynski, R. M., Grant, D. R., Clark, D. A., Phillips, M. J., Levy, G. A., 2003, The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis, J. Clin. Invest. 112:58-66.
2. Marazzi, S., Blum, S., Hartmann, R., Gundersen, D., Schreyer, M., Argraves, S., von Fliedner, V., Pytela, R., and Ruegg, C., 1998, Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes, J. Immunol. 161:138-147.
3. Herman, A. E., Freeman, G. J., Mathis, D., and Benoist, C., 2004, CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion, J. Exp. Med. 199:1479-1489.
4. Chan, C. W., Kay, L. S., Khadaroo, R. G., Chan, M. W., Lakatoo, S., Young, K. J., Zhang, L., Gorczynski, R. M., Cattral, M., Rotstein, O., and Levy, G. A., 2003, Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells, J. Immunol. 170:4036-4044.
5. Schiller, C., Janssen-Graalfs, I., Baumann, U., Schwerter-Strumpf, K., Izui, S., Takai, T., Schmidt, R. E., and Gessner, J. E., 2000, Mouse FcgammaRII is a negative regulator of FcgammaRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis, Eur. J. Immunol. 30:481-490.
6. Ravetch, J. V., and Kinet, J. P., 1991, Fc receptors, Annu. Rev. Immunol. 9:457-492.
7. Pricop, L., Redecha, P., Teillaud, J. L., Frey, J., Fridman, W. H., Sautes-Fridman, C., and Salmon, J. E., 2001, Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines, J. Immunol. 166:531-537.
8. Oleszak, E. L., Perlman, S., and Leibowitz, J. L., 1992, MHV S peplomer protein expressed by a recombinant vaccinia virus vector exhibits IgG Fc-receptor activity, Virology 186:122-132.
9. Johnson, D. C., Frame, M. C., Ligas, M. W., Cross, A. M., and Stow, N. D., 1988, Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI, J. Virol. 62:1347-1354.